Tomislav Vuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomislav Vuk has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Irena Jukić
Croatian Institute of Transfusion Medicine, Petrova 3, 10000 Zagreb, Croatia
14 shared publications Constantina Politis
Coordinating Centre for Haemovigilance and Surveillance of Transfusion, National Public Health Organization, Athens, Greece
4 shared publicationsMarijan Barišić
4 shared publicationsOlivier Garraud
SAINBIOSE-INSERM_U1059, faculty of medicine, University of Saint-Etienne, Saint-Etienne, France
4 shared publicationsT. Očić
Croatian Institute of Transfusion Medicine Zagreb Croatia
4 shared publicationsTihomir Očić
Croatian Institute of Transfusion Medicine Zagreb Croatia
4 shared publications
Latest Publications
- 17 November 2026
- Published by Wiley in Vox Sanguinis
Quality indicators for blood transfusion service laboratories: A proposal developed by the Quality Indicators Subgroup of the International Society of Blood Transfusion (ISBT) Quality Management Working Party
Background and Objectives: Given the diversity of laboratories operating within the blood transfusion service, the Quality Indicators Subgroup of the International Society of Blood Transfusion (ISBT) Quality Management Working Party recognized the need to define appropriate quality indicators for these laboratories, taking into account both shared processes and those specific to each type of laboratory. Materials and Methods: Quality indicators in this project are defined for the total laboratory process, and their selection for a particular laboratory is facilitated by indicating the suitability of each individual indicator for each of the three laboratory types: donor‐screening laboratories, quality control laboratories, and pre‐transfusion testing laboratories. Results: A total of 35 quality indicators were selected and described (19 in the pre‐analytical phase, 6 in the analytical phase, 5 in the post‐analytical phase, and 5 in supportive activities). All indicators are presented together with their corresponding numerators, denominators, and the type of laboratory in which their monitoring is considered appropriate. Conclusion: The outcomes of this project are expected to contribute to the harmonization of quality indicators used in transfusion services. The experience gained from the routine implementation of these indicators, along with feedback and suggestions from colleagues, would contribute to their validation and guide the further development of the project.
- 17 November 2026
- Published by Wiley in Vox Sanguinis
Quality indicators for blood transfusion service laboratories: A proposal developed by the Quality Indicators Subgroup of the International Society of Blood Transfusion (ISBT) Quality Management Working Party
Background and Objectives: Given the diversity of laboratories operating within the blood transfusion service, the Quality Indicators Subgroup of the International Society of Blood Transfusion (ISBT) Quality Management Working Party recognized the need to define appropriate quality indicators for these laboratories, taking into account both shared processes and those specific to each type of laboratory. Materials and Methods: Quality indicators in this project are defined for the total laboratory process, and their selection for a particular laboratory is facilitated by indicating the suitability of each individual indicator for each of the three laboratory types: donor‐screening laboratories, quality control laboratories, and pre‐transfusion testing laboratories. Results: A total of 35 quality indicators were selected and described (19 in the pre‐analytical phase, 6 in the analytical phase, 5 in the post‐analytical phase, and 5 in supportive activities). All indicators are presented together with their corresponding numerators, denominators, and the type of laboratory in which their monitoring is considered appropriate. Conclusion: The outcomes of this project are expected to contribute to the harmonization of quality indicators used in transfusion services. The experience gained from the routine implementation of these indicators, along with feedback and suggestions from colleagues, would contribute to their validation and guide the further development of the project.
- 13 April 2026
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 33 (3) , 198-199
THE IMPORTANCE OF EMERGENCY PLANNING IN SECURING BLOOD SUPPLIES DURING CRISES
- 13 April 2026
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 33 (3) , 198-199
THE IMPORTANCE OF EMERGENCY PLANNING IN SECURING BLOOD SUPPLIES DURING CRISES
- Open Access
- 4 January 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (3) , 254-261
Monitoring bacterial contamination of blood components at the Croatian Institute of Transfusion Medicine—Evolution of strategies and results in a 14‐year period (2011–2024)
Background and Objectives: This study presents the results and experiences of bacterial testing of blood components (BCs) at the Croatian Institute of Transfusion Medicine during the period 2011–2024. Materials and Methods: During the 14‐year period, 74,283 BCs were tested. Among these, 20,231 components (8345 red blood cell concentrates, 5729 platelet concentrates [PCs] and 6157 plasma units) were tested as part of statistical quality control (QC). In addition, 100% bacterial screening was implemented for aphaeresis platelets in November 2019 and for pooled platelets in October 2022 with 17,187 aphaeresis platelets and 36,865 pooled platelets tested by the end of 2024. All pooled platelets were tested using the large‐volume delayed sampling (LVDS) method, whereas 9596 aphaeresis platelets were tested using the two‐step method (from November 2019 to November 2022) and 7591 using LVDS (from November 2022 to December 2024). BCs were sampled and inoculated into both aerobic and anaerobic culture bottles and incubated at 36 ± 1°C for 7 days. Results: As part of the statistical QC, 20,231 BCs (5729 PCs) were tested, resulting in a confirmed contamination rate of 0.09% (0.14% for PCs). Since the implementation of universal screening, 54,052 PCs have been examined, with a confirmed positivity rate of 0.18%. The most frequently detected organism was Cutibacterium acnes . Conclusion: The confirmed positive rate of bacterial testing in our study and the isolates from positive cultures are comparable to similar studies. Active bacterial screening of BCs, among other measures, remains a critical step for preventing transfusion‐associated bacterial infections.
- 4 January 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (3) , 254-261
Open AccessMonitoring bacterial contamination of blood components at the Croatian Institute of Transfusion Medicine—Evolution of strategies and results in a 14‐year period (2011–2024)
Background and Objectives: This study presents the results and experiences of bacterial testing of blood components (BCs) at the Croatian Institute of Transfusion Medicine during the period 2011–2024. Materials and Methods: During the 14‐year period, 74,283 BCs were tested. Among these, 20,231 components (8345 red blood cell concentrates, 5729 platelet concentrates [PCs] and 6157 plasma units) were tested as part of statistical quality control (QC). In addition, 100% bacterial screening was implemented for aphaeresis platelets in November 2019 and for pooled platelets in October 2022 with 17,187 aphaeresis platelets and 36,865 pooled platelets tested by the end of 2024. All pooled platelets were tested using the large‐volume delayed sampling (LVDS) method, whereas 9596 aphaeresis platelets were tested using the two‐step method (from November 2019 to November 2022) and 7591 using LVDS (from November 2022 to December 2024). BCs were sampled and inoculated into both aerobic and anaerobic culture bottles and incubated at 36 ± 1°C for 7 days. Results: As part of the statistical QC, 20,231 BCs (5729 PCs) were tested, resulting in a confirmed contamination rate of 0.09% (0.14% for PCs). Since the implementation of universal screening, 54,052 PCs have been examined, with a confirmed positivity rate of 0.18%. The most frequently detected organism was Cutibacterium acnes . Conclusion: The confirmed positive rate of bacterial testing in our study and the isolates from positive cultures are comparable to similar studies. Active bacterial screening of BCs, among other measures, remains a critical step for preventing transfusion‐associated bacterial infections.
- 6 November 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 33 (1) , 40-44
Haemolysis of red cell concentrates during storage – The impact of donor factors
- 6 November 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 33 (1) , 40-44
Haemolysis of red cell concentrates during storage – The impact of donor factors
- 7 September 2025
- Published by Wiley in Vox Sanguinis
- Vol. 120 (12) , 1273-1282
Definitions used in quality management of blood establishments: A report of the ISBT Quality Management Working Party
Background and Objectives: The International Society of Blood Transfusion (ISBT) Quality Management Working Party (QM‐WP) initiated a project to harmonize the definitions commonly used in quality management within blood establishments (BEs) around the world. A working group was established with the aim of providing simple, unambiguous definitions that can be applied in a standardized way. Materials and Methods: Common references available internationally were consulted in drafting a list of definitions relating to quality management. The criteria for selecting the most appropriate definition included clarity, simplicity, comprehensiveness and optimal applicability. Results: The resulting list of definitions was published on the ISBT website in July 2023, with reference sources quoted for each definition. Individual references can be accessed via links appearing at the end of the document. Conclusion: BEs are encouraged to utilize the document when developing internal quality system documents. The list is not prescriptive but is meant to serve as a recommendation. It is understood, however, that establishments in some countries are obliged to follow national legislation and terminology. It is the intention of the ISBT QM‐WP to periodically review the list of definitions, performing updates when required.
- 7 September 2025
- Published by Wiley in Vox Sanguinis
- Vol. 120 (12) , 1273-1282
Definitions used in quality management of blood establishments: A report of the ISBT Quality Management Working Party
Background and Objectives: The International Society of Blood Transfusion (ISBT) Quality Management Working Party (QM‐WP) initiated a project to harmonize the definitions commonly used in quality management within blood establishments (BEs) around the world. A working group was established with the aim of providing simple, unambiguous definitions that can be applied in a standardized way. Materials and Methods: Common references available internationally were consulted in drafting a list of definitions relating to quality management. The criteria for selecting the most appropriate definition included clarity, simplicity, comprehensiveness and optimal applicability. Results: The resulting list of definitions was published on the ISBT website in July 2023, with reference sources quoted for each definition. Individual references can be accessed via links appearing at the end of the document. Conclusion: BEs are encouraged to utilize the document when developing internal quality system documents. The list is not prescriptive but is meant to serve as a recommendation. It is understood, however, that establishments in some countries are obliged to follow national legislation and terminology. It is the intention of the ISBT QM‐WP to periodically review the list of definitions, performing updates when required.
- 7 July 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (3) , 321-324
The future of quality management in transfusion medicine – From the new SoHO regulation and beyond
- 7 July 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (3) , 321-324
The future of quality management in transfusion medicine – From the new SoHO regulation and beyond
- 22 April 2025
- Published by Wiley in Vox Sanguinis
- Vol. 120 (7) , 734-745
Quality indicators for blood establishments and hospital blood banks: A report by the ISBT Quality Management Working Party
Background and Objectives: Quality monitoring is a key component of the quality management system, closely related to the concept of quality improvement. The implementation of quality indicators (QIs), as a valuable quality monitoring tool, contributes to the achievement of quality objectives.Materials and Methods: During 2010, discussions about the importance and use of QIs in transfusion medicine intensified, and 3 years later, the Quality Management Working Party (QM‐WP) of the International Society of Blood Transfusion (ISBT) published a set of QIs for blood establishments and hospital blood banks. QIs defined by ISBT QM‐WP were further developed and revised considering data obtained from an international survey on QIs, targeted consultations with members of the ISBT QM‐WP and individual expert opinions.Results: Several revisions of quality indicators proposed by ISBT QM‐WP have been published. The latest version from 2023 is presented in this paper and contains data on 50 QIs. Each indicator is defined, its importance is explained and the numerator and denominator required for its calculation are defined. The indicators are divided into seven groups according to areas of activity in the transfusion chain.Conclusion: This paper underlines the importance of QIs and provides resources for their selection, implementation and monitoring.
- 22 April 2025
- Published by Wiley in Vox Sanguinis
- Vol. 120 (7) , 734-745
Quality indicators for blood establishments and hospital blood banks: A report by the ISBT Quality Management Working Party
Background and Objectives: Quality monitoring is a key component of the quality management system, closely related to the concept of quality improvement. The implementation of quality indicators (QIs), as a valuable quality monitoring tool, contributes to the achievement of quality objectives.Materials and Methods: During 2010, discussions about the importance and use of QIs in transfusion medicine intensified, and 3 years later, the Quality Management Working Party (QM‐WP) of the International Society of Blood Transfusion (ISBT) published a set of QIs for blood establishments and hospital blood banks. QIs defined by ISBT QM‐WP were further developed and revised considering data obtained from an international survey on QIs, targeted consultations with members of the ISBT QM‐WP and individual expert opinions.Results: Several revisions of quality indicators proposed by ISBT QM‐WP have been published. The latest version from 2023 is presented in this paper and contains data on 50 QIs. Each indicator is defined, its importance is explained and the numerator and denominator required for its calculation are defined. The indicators are divided into seven groups according to areas of activity in the transfusion chain.Conclusion: This paper underlines the importance of QIs and provides resources for their selection, implementation and monitoring.
- 13 March 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (2) , 131-133
Donor vigilance – Current situation and future directions
- 13 March 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (2) , 131-133
Donor vigilance – Current situation and future directions
- 17 April 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (7) , 686-692
Aggregates in apheresis‐derived platelet concentrates: A 5‐year single‐centre experience
Background and Objectives: The phenomenon of aggregates in apheresis‐derived platelet concentrates (APCs) has not yet been fully elucidated. Initially, visible aggregates (IVA) usually dissolve within 24 h after collection, but some persist till the end of the shelf life (persistent aggregates, PA). A study conducted at the Croatian Institute of Transfusion Medicine aimed to identify factors that influence the aggregate occurrence in APCs.Materials and Methods: We conducted a cross‐sectional study for the 2018–2022 period and collected data on APCs with IVA. We analysed APCs discarded due to PA separately for two apheresis technologies and compared them to the control group.Results: Significantly more donations were discarded in the IVA group compared with the control group and total number of discarded APCs. A total of 205 APCs were discarded due to PA (14.7% of IVA APCs and 1.27% of all APCs collected). Amicus APCs with PA had a significantly lower platelet count and mean platelet volume. They were obtained by procedures with less anticoagulant used. In contrast to Amicus APCs, Haemonetics APCs with PA had a significantly higher platelet count. None of the donor‐related factors examined was predictive of PA.Conclusion: APCs with IVA are more often discarded, not only due to aggregates, but also for impairment of other quality control parameters. Type of apheresis technology, being one of the most common risk factors for IVA, was not confirmed as the main risk factor for PA. There seem to be some donor‐related causal factors.
- 17 April 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (7) , 686-692
Aggregates in apheresis‐derived platelet concentrates: A 5‐year single‐centre experience
Background and Objectives: The phenomenon of aggregates in apheresis‐derived platelet concentrates (APCs) has not yet been fully elucidated. Initially, visible aggregates (IVA) usually dissolve within 24 h after collection, but some persist till the end of the shelf life (persistent aggregates, PA). A study conducted at the Croatian Institute of Transfusion Medicine aimed to identify factors that influence the aggregate occurrence in APCs.Materials and Methods: We conducted a cross‐sectional study for the 2018–2022 period and collected data on APCs with IVA. We analysed APCs discarded due to PA separately for two apheresis technologies and compared them to the control group.Results: Significantly more donations were discarded in the IVA group compared with the control group and total number of discarded APCs. A total of 205 APCs were discarded due to PA (14.7% of IVA APCs and 1.27% of all APCs collected). Amicus APCs with PA had a significantly lower platelet count and mean platelet volume. They were obtained by procedures with less anticoagulant used. In contrast to Amicus APCs, Haemonetics APCs with PA had a significantly higher platelet count. None of the donor‐related factors examined was predictive of PA.Conclusion: APCs with IVA are more often discarded, not only due to aggregates, but also for impairment of other quality control parameters. Type of apheresis technology, being one of the most common risk factors for IVA, was not confirmed as the main risk factor for PA. There seem to be some donor‐related causal factors.
- 10 February 2023
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 30 (2) , 294-302
Education in transfusion medicine, Part III – The importance of haemovigilance education
- 10 February 2023
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 30 (2) , 294-302
Education in transfusion medicine, Part III – The importance of haemovigilance education